Moved Permanently

The document has moved here. Integrated R & D Services – WuXi AppTec - 龙8国际唯一授权_龙8国际娱乐注册_龙8国际是什么
×


Full Range of Analytical & Regulatory CMC Services

The Analytical Service Unit supports clients from preclinical phases through market supply. Our flexible analytical solutions are available as part of an IND- or NDA-enabling package, as well as on a standalone basis. As part of our integrated approach, the Analytical Service Unit works in close collaboration with the DMPK, Bioanalytical and Toxicology units within the Laboratory Testing Division, allowing our highly-skilled teams to leverage their complementary capabilities to deliver the highest quality data with speed and efficiency.

Service & Quality

Our analytical programs include API and drug product method development and validation and release, manufacturing support, IND and NDA enabling stability studies, reference standard qualification, impurity control, preformulation and product characterization. Our technical writers provide regulatory CMC support by composing IND and NDA packages, and have a proven record of successful submission of these packages to global regulatory agencies. Our commitment to world-class quality has been validated by government agencies as well as numerous clients, and we adhere to strict project and process management standards for all studies.

Early & Late Phase Analytical Development

 

Stability Studies

 

Impurity Research

 

Highly Potent Compound Analysis

 

Large Molecule Analysis

 

Microbial Testing

 

Preformulation Study

 

Physiochemical Characterization & Excipient Release

 

Regulatory CMC

 

Track Record of Success

From method development and validation to NDA preparation and submission, the Analytical Service Unit is your single solution for analytical development and regulatory support, having conducted stability programs for more than 2,000 batches of API and drug product and preparing over 50 CMC dossiers to date.
330
Customers for Discovery Chemistry & Separation, API & Clinical Trial Material Manufacturing
1,000
Stability Programs Conducted for 1,000 Batches of API & Drug Products
25
INDs / NDAs Submitted to FDA
20
CTDs / CTAs Submitted to CFDA

Operations & Compliance

The Analytical Services Unit operates in full compliance with FDA, MPA, CFDA and GMP requirements, which is validated through regular inspections by both regulatory authorities as well as our clients. Each of our employees undergoes a systematic training regimen that covers analytical sciences, GMP compliance, workflow operations and standard operating procedures to ensure our quality standards are consistently being met across the division. + 220+ GMP Client-Initiated Audits Since 2009
+ FDA Inspections in 2014 and 2016
+ MPA Inspections in 2009, 2012 and 2016
+ Numerous CFDA Inspections
+ Electronic Data Handling Compliant with FDA 21 CFR Part 11
+ Periodic Inspections & Data Completeness Review from Independent QAU
+ Highly Capable Team of 400+ Staff Across Analytical Development, Stability and Regulatory CMC

Bioanalytical Services

 

Toxicology Services

 

DMPK Services